Intravitreal anti-VEGF therapy is not associated with a higher risk of all-cause mortality in patients with macular oedema caused by posterior segment vascular diseases

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalActa Ophthalmologica
Number of pages6
Publication statusE-pub ahead of print - 2 Jan 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • all&#8208
  • cause mortality
  • anti&#8208
  • VEGF
  • diabetic macular oedema
  • retinal vein occlusion
  • wet age&#8208
  • related macular degeneration

Cite this